Full Text View
Tabular View
No Study Results Posted
Related Studies
Rosiglitazone Versus Theophylline in Asthmatic Smokers
This study has been completed.
Study NCT00119496   Information provided by University of Glasgow
First Received: July 1, 2005   Last Updated: March 19, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Asthma
More general conditions related to this trial
Bronchial Diseases
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Lung Diseases
Lung Diseases, Obstructive
Respiratory Hypersensitivity
Respiratory Tract Diseases
Interventions listed in this trial
rosiglitazone
theophylline
beclomethasone
More general drug interventions related to this trial
Anti-Asthmatic Agents
Anti-Inflammatory Agents
Autonomic Agents
Bronchodilator Agents
Cardiovascular Agents
Enzyme Inhibitors
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Hypoglycemic Agents
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Phosphodiesterase Inhibitors
Physiological Effects of Drugs
Respiratory System Agents
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
University of Glasgow
GlaxoSmithKline
Chest, Heart and Stroke Association Scotland
Chief Scientists Office


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services